The study was conducted on people with Down’s syndrome in Damascus,
through a questionnaire distributed to the families of those infected and
affiliated with associations. The results showed that females are more infected
than males, with 62% females, while males are 38, 33% people with Down’s
syndrome were found to be aged 10 and under, 24% ranging from 11-21 years old, 43% aged 22-30 years old and no older than 30 years old. The
psychological and moral consequences of Down’s syndrome were such that 24% were
trying to keep the patient out of sight and 62% were not trying to hide them
and how to treat Down’s syndrome sufferers and their needs in order to make
them disadvantaged.
References
[1]
Batshaw, M. (Ed.) (2005). Children with Disabilities (5th ed., p. 308). Paul H. Brookes.
[2]
Bhatnagar, N., Nizery, L., Tunstall, O., Vyas, P., & Roberts, I. (2016). Transient Abnormal Myelopoiesis and AML in Down Syndrome: An Update. Current Hematologic Malignancy Reports, 11, 333-341. https://doi.org/10.1007/s11899-016-0338-x
[3]
Bull, M. J. (2011). Committee on Genetics, American Academy of Pediatrics. Health Supervision for Children with Down Syndrome. Pediatrics, 128, 393-406. https://doi.org/10.1542/peds.2011-1605
[4]
CDC [Centers for Disease Control and Prevention] (2013). CDC—Birth Defects, Down Syndrome—NCBDDD. Cdc.gov. https://www.cdc.gov
[5]
CDC [Centers for Disease Control and Prevention] (2021, April 6). Facts about Down Syndrome. https://www.cdc.gov
[6]
David, A. K. (2013). Family Medicine Principles and Practice (6th ed., p. 142). Springer.
[7]
Domino, F. J. (Ed.) (2007). The 5-Minute Clinical Consult 2007 (2007 ed., p. 392). Lippincott Williams & Wilkins.
[8]
Down Syndrome—Symptoms and Causes (yr). Mayo Clinic. http://www.mayoclinic.org
[9]
Epstein, C. J. (2007). The Consequences of Chromosome Imbalance: Principles, Mechanisms, and Models (pp. 255-256). Cambridge University Press.
[10]
Fay, E.-M. F. (2009). Down Syndrome (p. 71). Chelsea House.
[11]
Fletcher-Janzen, E. (2007). Encyclopedia of Special Education: A Reference for the Education of Children, Adolescents, and Adults with Disabilities and Other Exceptional Individuals (C. R. Reynolds, Ed., 3rd ed., p. 458). John Wiley & Sons.
[12]
Gamis, A. S., & Smith, F. O. (Nov 2012). Transient Myeloproliferative Disorder in Children with Down Syndrome: Clarity to This Enigmatic Disorder. British Journal of Haematology, 159, 277-287. https://doi.org/10.1111/bjh.12041
[13]
Gardner, R. J. M., Sutherland, G. R., & Shaffer, L. G. (2011). Chromosome Abnormalities and Genetic Counseling (4th ed., p. 292). Oxford University Press. https://doi.org/10.1093/med/9780195375336.001.0001
[14]
Goldstein, S. (Ed.) (2011). Handbook of Neurodevelopmental and Genetic Disorders in children (2nd ed., p. 365). Guilford Press.
[15]
Graber, E., Chacko, E., Regelmann, M. O., Costin, G., & Rapaport, R. (2012). Down Syndrome and Thyroid Function. Endocrinology and Metabolism Clinics of North America, 41, 735-745. https://doi.org/10.1016/j.ecl.2012.08.008
[16]
Hammer, G. D. (2010). Pathophysiology of Selected Genetic Diseases. In S. J. McPhee (Ed.), Pathophysiology of Disease: An Introduction to Clinical Medicine (6th ed., Chapter 2). McGraw-Hill Medical.
[17]
Hickey, F., Hickey, E., & Summar, K. L. (2012). Medical Update for Children with Down Syndrome for the Pediatrician and Family Practitioner. Advances in Pediatrics, 59, 137-157. https://doi.org/10.1016/j.yapd.2012.04.006
[18]
Howard, R. (2013). Essentials of Rubin’s Pathology (pp. 129-131). Lippincott Williams & Wilkins.
[19]
Kausik, M. (2013). Treatment & Prognosis in Pediatrics (p. 391). Jaypee Brothers.
[20]
Kent, R. D., & Vorperian, H. K. (2013). Speech Impairment in Down Syndrome: A Review. Journal of Speech, Language, and Hearing Research, 56, 178-210. https://doi.org/10.1044/1092-4388(2012/12-0148)
[21]
Kliegma, R. M. (2011). Down Syndrome and Other Abnormalities of Chromosome Number. In J. Nelson (Ed.), Nelson Textbook of Pediatrics (19th ed., p. 76, Chapter 2). Saunders.
[22]
Lana-Elola, E., Watson-Scales, S. D., Fisher, E. M., & Tybulewicz, V. L. (2011). Down Syndrome: Searching for the Genetic Culprits. Disease Models & Mechanisms, 4, 586-595. https://doi.org/10.1242/dmm.008078
[23]
Lee, P., Bhansali, R., Izraeli, S., Hijiya, N., & Crispino, J. D. (2016). The Biology, Pathogenesis and Clinical Aspects of Acute Lymphoblastic Leukemia in Children with Down Syndrome. Leukemia, 30, 1816-1823. https://doi.org/10.1038/leu.2016.164
[24]
Mai, C. T., Isenburg, J. L., Canfield, M. A., Meyer, R. E., Correa, A., Alverson, C. J., Lupo P. J., Riehle-Colarusso, T., Cho, S. J., Aggarwal, D., & Kirby, R. S. (2019). National Population-Based Estimates for Major Birth Defects, 2010-2014. Birth Defects Research, 111, 1420-1435. https://doi.org/10.1002/bdr2.1589
[25]
Malt, E. A., Dahl, R. C., Haugsand, T. M., Ulvestad, I. H., Emilsen, N. M., Hansen, B., Cardenas, Y. E., Skøld, R. O., Thorsen, A. T., & Davidsen, E. M. (2013). Health and Disease in Adults with Down Syndrome. Tidsskrift for den Norske Laegeforening, 133, 290-294. https://doi.org/10.4045/tidsskr.12.0390
[26]
Margulies, P. (2007). Down Syndrome (1st ed., p. 5). Rosen Pub. Group.
[27]
McGuire, D., & Chicoine, B. (2006). Mental Wellness in Adults with Down Syndrome (p. 49). Woodbine House, Inc.
[28]
Melmed, S., Polonsky, K. S., Reed Larsen, P., & Kronenberg, H. M. (2011). Williams Textbook of Endocrinology Expert Consult (12th ed.). Elsevier Health Sciences.
[29]
Menkes, J. H., & Sarnat, H. B. (2005). Child Neurology (7th ed., p. 228). Lippincott Williams & Wilkins.
[30]
Michael, C. (2013). Human Heredity: Principles and Issues (10 ed., p. 138). Cengage Learning.
[31]
National Down Syndrome Society (2022). What Is Down Syndrome? National Down Syndrome Society. http://ndss.org
[32]
Nelson, M. R. (2011). Pediatrics (p. 88). Demos Medical.
[33]
Patterson, D. (2009). Molecular Genetic Analysis of Down Syndrome. Human Genetics. 126, 195-214. https://doi.org/10.1007/s00439-009-0696-8
[34]
Patterson, T., Rapsey, C. M., & Glue, P. (2013). Systematic Review of Cognitive Development across Childhood in Down Syndrome: Implications for Treatment Interventions. Journal of Intellectual Disability Research, 57, 306-318. https://doi.org/10.1111/j.1365-2788.2012.01536.x
[35]
Prasher, V. P. (2009). Neuropsychological Assessments of Dementia in Down Syndrome and Intellectual Disabilities (p. 56). Springer. https://doi.org/10.1007/978-1-84800-249-4
[36]
Reilly, C. (2012). Behavioural Phenotypes and Special Educational Needs: Is Aetiology Important in the Classroom? Journal of Intellectual Disability Research, 56, 929-946. https://doi.org/10.1111/j.1365-2788.2012.01542.x
[37]
Rodman, R., & Pine, H. S. (2012). The Otolaryngologist’s Approach to the Patient with Down Syndrome. Otolaryngologic Clinics of North America, 45, 599-629. https://doi.org/10.1016/j.otc.2012.03.010
[38]
Rondal, J.-A., & Quartino, A. R. (Eds.) (2007). Therapies and Rehabilitation in Down Syndrome (p. 116). John Wiley & Sons.
[39]
Seewald, L., Taub, J. W., Maloney, K. W., & McCabe, E. R. (2012). Acute Leukemias in Children with Down Syndrome. Molecular Genetics and Metabolism, 107, 25-30. https://doi.org/10.1016/j.ymgme.2012.07.011
[40]
Strauss, J. F., & Barbieri, R. L. (2009). Yen and Jaffe’s Reproductive Endocrinology: Physiology, Pathophysiology, and Clinical Management (6th ed., p. 791). Saunders/Elsevier.
[41]
Tamblyn, J. A., Norton, A., Spurgeon, L., Donovan, V., Bedford Russell, A., Bonnici, J., Perkins, K., Vyas, P., Roberts, I., & Kilby, M. D. (2016). Prenatal Therapy in Transient Abnormal Myelopoiesis: A Systematic Review. Archives of Disease in Childhood: Fetal and Neonatal Edition, 101, 67-71. https://doi.org/10.1136/archdischild-2014-308004
[42]
Tintinalli, J. E. (2010). The Child with Special Health Care Needs. In Emergency Medicine: A Comprehensive Study Guide (Emergency Medicine (Tintinalli)) (pp. Chapter 138). McGraw-Hill Companies.
[43]
Weijerman, M. E., & de Winter, J. P. (2010). Clinical Practice. The Care of Children with Down Syndrome. European Journal of Pediatrics, 169, 1445-1452. https://doi.org/10.1007/s00431-010-1253-0
[44]
William, S. M (Ed.) (2012). The 5-Minute Pediatric Consult (6th ed., p. 289). Wolters Kluwer Health/Lippincott Williams & Wilkins.
[45]
Zhang, D. Y. (2008). Molecular Genetic Pathology (Cheng, Liang, ed., p. 45). Humana.
